| Certificates/Standards: | N; |
| Monthly Output: | Not provided |
| Regional: | Not provided |
| Packaging Information: | Not provided |
| Mode Of Payment: | Not provided |
| Delivery Lead Time: | Not provided |
| Main Sales Markets: | North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa |
| Sample Provided: | No |
| Sample Policy: | Not provided |
| Minimum Quantity: | Not provided |
"Liposovit®-C is liposomal vitamin C available in the form of fine, free-flowing, homogeneous powder, intended
for multi-factorial support of the body in states of increased demand for L-ascorbic acid. As a result of the work
of BART's Research & Development Department, we obtained liposomes composed of a single bilayer of
phosphatidylcholine (lecithin) molecules, which is the external barrier of the liposomal vesicle and entraps
L-ascorbic acid (vitamin C) molecules in the hydrophilic space (Figure 1). These liposomes have been subjected
to drying process, which largely determines the special properties of the product.
Liposovit®-C developed by us:
protects vitamin C from chemical and enzymatic degradation during storage
and during transit through the digestive tract,
protects gastrointestinal epithelium of the consumer from irritation resulting from taking increased doses of vitamin C,
as confirmed by the clinical trial, in comparison with vitamin C in its conventional form, enables to:
boost supplementation in a statistically significant manner, i.e. achieve an equivalent therapeutic
effect at lower doses of the active substance,
obtain a much better absorption of vitamin C into the bloodstream, which is equivalent to
its higher bioavailability,
prolong the presence of increased vitamin C concentration in the blood and, as a result, ensure its longer action,
enables slow and sustained release of vitamin C from the liposomal vesicle,
is fully safe, biodegradable and biocompatible."